Regulated information

Monthly information regarding the total number of voting rights and shares making of the share capital -Aout 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

Programme de rachat - August 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

Vetoquinol finalizes the acquisition of Profender® and Drontal® product families

September 1st, 2020 (Lure, France) – Vetoquinol confirms the completion of the acquisition of Profender® and Drontal® product families for the European Economic Area and the UK. This acquisition is effective from August 1st, 2020.

Programme de rachat - July 2020

Tableau de déclaration mensuelle des opérations réalisées par un émetteur sur ses propres titres

Monthly information regarding the total number of voting rights and shares making of the share capital -July 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers » 

2020 Half year Financial Report (french)

Half year Financial Report

[VIDEO] Présentation des résultats semestriels 2020 - french

H1 2020 results

H1 2020 Result

2020 first half results consolidated sales: €196.1m (up 7.5% at constant exchange rates) net income group share: €15.1m (7.7% of sales)

At its meeting on July 29, 2020, the Vetoquinol S.A. Board of Directors reviewed the Group results and approved the first half 2020 financial statements. The auditors have completed their audit of the financial statements and will shortly issue their report thereon.

Monthly information regarding the total number of voting rights and shares making of the share capital -June 2020

As per article 223.16 of the « Règlement Général de « L’Autorité des Marchés Financiers »